MiniMed Group, Inc. (MMED): R&D Expense

Annual figures by period end, from SEC filings.

$448.00M

Year ended 2026-04-24

$438.00M

Trailing 12 months to 2026-07-31

2024-04-26 R&D Expense (USD) 2026-04-24

Period ended	R&D Expense	Change YoY	Source filing
2026-04-24	$448.00M	+2.8%	2026-06-29, From 2025-04-26
2025-04-25	$436.00M	-0.2%	2026-06-29, From 2024-04-27
2024-04-26	$437.00M	n/a	2026-06-29, From 2023-04-29

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
MiniMed Group, Inc. (MMED)	2026-04-24	$448.00M	+2.8%
West Pharmaceutical Services Inc (WST)	2025-12-31	$74.30M	+7.5%
Globus Medical Inc (GMED)	2025-12-31	$147.25M	-10.1%
Insulet Corp (PODD)	2025-12-31	$301.10M	+37.1%
ICU Medical Inc (ICUI)	2025-12-31	$87.50M	-1.3%
Dexcom Inc (DXCM)	2025-12-31	$599.10M	+8.5%
Teleflex Inc (TFX)	2025-12-31	$144.78M	+32.8%
ResMed Inc (RMD)	2026-06-30	$378.29M	+14.2%
Integra Lifesciences Holdings Corp (IART)	2025-12-31	$98.97M	-14.2%

Compare MMED, WST, GMED, PODD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗